Alameda based BioTime, Inc., a company that develops and markets products in the field of stem cells and regenerative medicine, has recently signed an agreement to acquire Glycosan BioSystems. While our location will change, Glycosan's core business will remain the same—providing you the highest quality hydrogels for research and development and soon for clinical use.

Glenn D. Prestwich, CSO and Cofounder of Glycosan BioSystems, has just been awarded the "2010 Distinguished Scholarly and Creative Research Award" from the University of Utah; read the story here.